Urinalysis Market – Global Outlook & Forecast 2021-2031

Urinalysis Market by Test Type [Biochemical Urinalysis and Sediment Urinalysis], Product Type [Consumables and Instruments], Application [Pregnancy Tests and Disease Diagnostics], End User [Hospitals and Diagnostics Centers] – Global Analysis & Forecast 2021-2031

Clairvoyance Research conducted an in-depth market analysis study of the global urinalysis market. According to study, the market was valued at ~US$ 3.5 billion in 2020. The market is expected to witness a CAGR of ~6.5% from 2021 to 2031. 

Rising prevalence of kidney diseases & urinary tract infections (UTIs), growing adoption of point-of-care (PoC) urinalysis testing, favorable government policies, and launch of technological advanced urinalysis solutions are some of the pivotal factors propelling the growth of the urinalysis market. However, dearth of skilled laboratory professionals and limitations of urine dipstick testing are likely to hamper the growth of the market to a certain extent.

With an aim to fast-track the development of urinalysis and to meet the needs of the healthcare sector, several initiatives such as providing necessary grants, permissions, clearances & approvals have been instigated by various organizations and government agencies across the world. For instance, in Mar 2019, The Dip.io urinalysis test system from Israeli-based Healthy.io received FDA 510(k) clearance for smartphone-based urinalysis test kit for at-home use.

Kidney disease is a ‘Hidden Epidemic’ that is growing profusely and poses a significant health care challenge, particularly in low- and middle-income countries. Kidney diseases are the 11^th leading cause of death globally. It is touted as “Silent Disease” as most often there are no apparent early symptoms and most people are not aware of their impaired kidney function. According to International Society of Nephrology (ISN), over 850 million people worldwide have some form of kidney disease. This number is roughly double the number of people who live with diabetes and 20 times more than the prevalence of cancer worldwide or people living with AIDS/HIV. Urinary tract infection (UTI) is another significant health problem in both community and hospital–based settings. It is one of the most common disease that affects all age groups ranging from neonates to the geriatric population. It is estimated that approximately 150 million UTIs occur annually world-wide.

The adoption of point-of-care urinalysis testing has increased in the recent years. Point of care urinalysis offers fast and accurate results within minutes with a wide menu of analytes. It is used to detect and measure the level of various substances in the urine, including albumin, creatinine, protein, glucose, ketones, blood, urea/blood urea nitrogen (BUN) and other substances. The most persuasive benefit of these tests is that, as opposed to having to wait hours or days for results to arrive from an outside laboratory, clinicians can obtain the results immediately, allowing for clinical management decisions to be made while the patient is still at the care facility.

However, shortage of skilled laboratory professionals may hamper the growth of the market to a certain extent. Laboratories are continuously striving to get all of their work done with reduced lab resources, or trying to accomplish more work with the same number of resources.

The Asia Pacific region is expected be the fastest growing urinalysis market. Factors such as developing healthcare infrastructure, increasing penetration rate of advanced urine analyzers and large base of target population with unmet clinical needs can be attributed to the growth of the market. Countries such as India, China, Japan in the APAC region, are projected to offer significant growth opportunities owing to increasing prevalence of kidney diseases and rising geriatric population in the region.

The market is marked by presence of prominent players such as F. Hoffmann-La Roche Ltd, Sysmex, Beckman Coulter, Inc., ARKRAY USA, Inc., Siemens Healthcare GmbH, Abbott, Bio-Rad Laboratories, Inc., ACON Laboratories, Inc., URIT Medical Electronic Co., Ltd., 77 Elektronika Kft. Other players operating in the market Cardinal Health, Quidel Corporation, among others.

About Us

Clairvoyance Research is a leading market research and consulting firm, based out in Kolkata, India. Our research solutions are structured around the following verticals: Healthcare (Medical Devices, Biotechnology, Healthcare IT, Pharmaceuticals, and Others), Food & Beverage, Consumer Goods, Automotive & Transportation, Chemicals & Materials & Others.

Our main offerings are syndicate reports and consulting assignments – We track a number of verticals and strategically publish syndicate reports on topics that have traction in the market. Over the years, we have developed a forte in executing consulting assignments – Clairvoyance Research has been a trusted partner to over 300 global organizations including Fortune 500 companies. We partner with clients from across the globe to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. We have a rich pool of clientele spanning leading medical device/biotechnology/healthcare IT/pharmaceutical companies, IT/FMCG/automotive/food & beverage companies, consulting companies, private equity firms, venture capitalists, investment banks, government bodies, academic/research institutes, and universities.

We internally house one of the best talents in the industry – Industry Veterans [Subject Matter Experts (SMEs), Key Opinion Leaders (KOLs)] from different verticals with a profound experience of several decades are there on our panel. At each stage of the study, these experts add value to our reports and consulting assignments. We nurture crème de la crème resources; our analysts/consultants come from robust educational backgrounds. The rich pool of experts and analysts/consultants at Clairvoyance Research ensures that the final research study is accurate, universally accepted, and of the highest quality.

Contact Us

[email protected]

Website: www.clairvoyanceresearch.com